Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients
By Robert R. Conley, MD and Deanna L. Kelly, PharmD, BCPP
Comparing the Methods Used to Compare Antidepressants
By Michael E. Thase, MD
Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder
By Michael E. Thase, MD, and Madhukar Trivedi, MD
Depression Treatment: A Lifelong Commitment?
By Martin B. Keller, MD, and Ernst R. Berndt, PhD
The History of Valproate in Clinical Neuroscience
By Thomas R. Henry, MD
Androgens and the Aging Male
By Stuart N. Seidman, MD
La fobia social en una muestra de pacientes Españoles con trastorno de pánico
Dr. Juan Seguí, Dr. Manuel Márquez, Dr. Luis García, Dr. Jaume Canet y Mtra. Mercedes Ortiz
La guía 2016 sobre interacciones entre medicamentos psicotrópicos, Part 2
C. Lindsay DeVane, PharmD y Charles B. Nemeroff, MD, PhD